Eli Lilly Dealt Another Setback as Lung Cancer Drug Flunks Phase III Test Post author:Sam Post published:October 9, 2017 Post category:BioPharma October 10, 2017By Alex Keown, BioSpace.com Breaking… Source: BioSpace You Might Also Like Deal Spree Continues as Allergan Inks $2.47 Billion Deal for This Bay Area Biotech February 12, 2017 Rigel Pharma Awaits FDA Approval for Tavalisse, Builds Commercial Org for Drug Launch January 14, 2018 McKesson Reports Fiscal 2017 Fourth-Quarter And Full-Year Results May 18, 2017
Rigel Pharma Awaits FDA Approval for Tavalisse, Builds Commercial Org for Drug Launch January 14, 2018
